Quality-of-Life Analysis in Vestibular Schwannoma
Dr. Link shares insights from his extensive research on how vestibular schwannomas affect quality of life, and how different treatment paths impact patient outcomes. He also introduces a new quality of life instrument developed by his team to better capture the lived experiences of patients. Drawing on decades of clinical and academic expertise, Dr. Link explores the evolving landscape of patient-centered care.
World of Acoustic Neuroma Symposium 2024: Updates in Vestibular Schwannoma: Toward Increasingly Personalized Care
Dr. Alexander Landry presented on the molecular biology of vestibular schwannomas, highlighting research breakthroughs that may enable earlier detection and new treatments. The session was introduced by Dr. Farshad Nassiri, who emphasized ANAC’s commitment to improving patient access to specialists and high-quality care.
Revisiting the Molecular Landscape of Vestibular Schwannoma
Dr. Landry’s webinar explored his team’s research into the genetics of vestibular schwannoma. By identifying two distinct molecular subgroups, the study points to promising new treatment options beyond surgery and radiation, including immune checkpoint inhibitors and repurposed drugs. His talk offered hope for more personalized therapies in the future.
